Recognition of endogenously synthesized HLA-DR4 restricted HCV epitopes presented by autologous EBV transformed B-lymphoblastoid cell line

Vaccine

Volumn 23, Issue 7, 2005, Pages 951-962

  Yang, Meiying ^a   Zhu, Fenlu ^a   Sønderstrup, Grete ^b   Eckels, David D ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endogenous antigen presentation; HCV epitopes; Minigene vaccine

Indexed keywords

AUTOANTIGEN; DNA VACCINE; EPITOPE; HLA DR4 ANTIGEN; INTERLEUKIN 2;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; EPSTEIN BARR VIRUS; GENE EXPRESSION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; B-LYMPHOCYTES; BASE SEQUENCE; CELL LINE; CELL LINE, TRANSFORMED; EPITOPES, B-LYMPHOCYTE; HEPATITIS C ANTIGENS; HERPESVIRUS 4, HUMAN; HLA-DR4 ANTIGEN; HUMANS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA;

EID: 10444223015     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.06.034     Document Type: Article

References (50)

1. J. Cohen The scientific challenge of hepatitis C Science 285 5424 1999 26 30
2. P.G. Plagemann Hepatitis C virus Arch Virol. 120 3-4 1991 165 180
3. D.D. Eckels, H. Wang, T.H. Bian, N. Tabatabai, and J.C. Gill Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T-cells in HCV infection Immunol. Rev. 174 2000 90 97
4. H.M. Diepolder, R. Zachoval, R.M. Hoffmann, E.A. Wierenga, T. Santantonio, and M.C. Jung Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection Lancet 346 8981 1995 1006 1007
5. G. Missale, R. Bertoni, V. Lamonaca, A. Valli, M. Massari, and C. Mori Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response J. Clin. Invest. 98 3 1996 706 714
6. + response to hepatitis C and severity of recurrence after liver transplantation Gastroenterology 117 4 1999 926 932
7. + T-cell response in acute hepatitis C Gastroenterology 117 4 1999 933 941
8. J.J. Donnelly, J.B. Ulmer, J.W. Shiver, and M.A. Liu DNA vaccines Annu. Rev. Immunol. 15 1997 617 648
9. M. Chen, M. Sallberg, A. Sonnerborg, O. Weiland, L. Mattsson, and L. Jin Limited humoral immunity in hepatitis C virus infection Gastroenterology 116 1 1999 135 143
10. J.A. Wolff, R.W. Malone, P. Williams, W. Chong, G. Acsadi, and A. Jani Direct gene transfer into mouse muscle in vivo Science 247 4949 Pt 1 1990 1465 1468
11. M. Chang, A.P. Marquardt, B.L. Wood, O. Williams, S.J. Cotler, and S.L. Taylor In situ distribution of hepatitis C virus replicative-intermediate RNA in hepatic tissue and its correlation with liver disease J. Virol. 74 2 2000 944 955
12. S. Cooper, A.L. Erickson, E.J. Adams, J. Kansopon, A.J. Weiner, and D.Y. Chien Analysis of a successful immune response against hepatitis C virus Immunity 10 4 1999 439 449
13. F. Lechner, D.K. Wong, P.R. Dunbar, R. Chapman, R.T. Chung, and P. Dohrenwend Analysis of successful immune responses in persons infected with hepatitis C virus J. Exp. Med. 191 9 2000 1499 1512
14. L.G. Guidotti, K. Ando, M.V. Hobbs, T. Ishikawa, L. Runkel, and R.D. Schreiber T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice Proc. Natl. Acad. Sci. USA 91 9 1994 3764 3768
15. L.G. Guidotti, and F.V. Chisari Noncytolytic control of viral infections by the innate and adaptive immune response Annu. Rev. Immunol. 19 2001 65 91
16. L.G. Guidotti, P. Borrow, A. Brown, H. McClary, R. Koch, and F.V. Chisari Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte J. Exp. Med. 189 10 1999 1555 1564
17. N.M. Tabatabai, T.H. Bian, C.M. Rice, Yoshizawa, J. Gill, and D.D. Eckels Functionally distinct T-cell epitopes within the hepatitis C virus non-structural 3 protein Hum. Immunol. 60 2 1999 105 115
18. H. Wang, and D.D. Eckels Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for T cell recognition J. Immunol. 162 7 1999 4177 4183
19. J.H. Wang, T.J. Layden, and D.D. Eckels Modulation of the peripheral T-Cell response by CD4 mutants of hepatitis C virus: transition from a Th1 to a Th2 response Hum. Immunol. 64 7 2003 662 673
20. D.D. Eckels, T. Bian, J.C. Gill, and G. Sonderstrup Epitopes of the NS3 protein of hepatitis C virus: recognition in HLA-DR4 transgenic mice Immunol. Cell Biol. 80 1 2002 106 112
21. D.D. Eckels, N. Tabatabail, T.H. Bian, H. Wang, S.S. Muheisen, and C.M. Rice In vitro human Th-cell responses to a recombinant hepatitis C virus antigen: failure in IL-2 production despite proliferation Hum. Immunol. 60 3 1999 187 199
22. R.M. Horton, H.D. Hunt, S.N. Ho, J.K. Pullen, and L.R. Pease Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension Gene 77 1 1989 61 68
23. O. Mazda, K. Teshigawara, S. Fujimoto, N. Hattori, Y.M. Dou, and Y. Katsura A reporter system using a flow cytometer to detect promoter/enhancer activity in lymphoid cell lines J. Immunol. Methods 169 1 1994 53 61
24. R.N. Germain, and D.H. Margulies The biochemistry and cell biology of antigen processing and presentation Annu. Rev. Immunol. 11 1993 403 450
25. Y. Jin, W.K. Shih, and I. Berkower Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen J. Exp. Med. 168 1 1988 293 306
26. + T cells J. Virol. 72 10 1998 8301 8308
27. M.S. Malnati, M. Marti, T. LaVaute, D. Jaraquemada, W. Biddison, and R. DeMars Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells Nature 357 6380 1992 702 704
28. J.G. Nuchtern, W.E. Biddison, and R.D. Klausner Class II MHC molecules can use the endogenous pathway of antigen presentation Nature 343 6253 1990 74 76
29. L.C. Bonifaz, S. Arzate, and J. Moreno Endogenous and exogenous forms of the same antigen are processed from different pools to bind MHC class II molecules in endocytic compartments Eur. J. Immunol. 29 1 1999 119 131
30. L. Qi, and S. Ostrand-Rosenberg MHC class II presentation of endogenous tumor antigen by cellular vaccines depends on the endocytic pathway but not H2-M Traffic 1 2 2000 152 160
31. + T-cell line by a transfected B-cell line Immunology 86 1 1995 116 121
32. N. Himoudi, J.D. Abraham, A. Fournillier, Y.C. Lone, A. Joubert, and A. Op De Beeck Comparative vaccine studies in HLA-A2.1-transgenic mice reveal a clustered organization of epitopes presented in hepatitis C virus natural infection J. Virol. 76 24 2002 12735 12746
33. A. Bertoletti, and M.K. Maini Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? Curr. Opin. Immunol. Rev. 12 4 2000 403 408
34. + T cells J. Exp. Med. 174 1991 875 880
35. D. Kagi, P. Seiler, J. Pavlovic, B. Ledermann, K. Burki, and R.M. Zinkernagel The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses Eur. J. Immunol. 25 1995 3256 3262
36. P.A. Scherle, G. Palladino, and W. Gerhard Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells J. Immunol. 148 1992 212 217
37. + T helper type 2 T lymphocytes do not promote recovery from experimental virus infection J. Exp. Med. 180 1994 1273 1282
38. + T cell subsets during virus infection. Protective capacity depends on effector cytokine secretion and on migratory capability J. Exp. Med. 191 2000 2159 2170
39. A. Franco, L.G. Guidotti, M.V. Hobbs, V. Pasquetto, and F.V. Chisari Pathogenetic effector function of CD4-positive T-helper-1 cells in hepatitis B virus transgenic mice J. Immunol. 159 1997 2001 2008
40. + T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection J Virol. 71 8 1997 6011 6019
41. + T cells: implications for vaccine development Hepatology 30 4 1999 1088 1098
42. L. Adorini, J.C. Guery, S. Fuchs, V. Ortiz-Navarrete, G.J. Hammerling, and F. Momburg Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II-restricted T cells J. Immunol. 151 7 1993 3576 3586
43. + T cells that are dependent on MHC class II-bound peptide-flanking residues J. Immunol. 169 2 2002 739 749
44. + T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope J. Exp. Med. 176 5 1992 1335 1341
45. M. Del Val, H.J. Schlicht, T. Ruppert, M.J. Reddehase, and U.H. Koszinowski Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein Cell 66 6 1991 1145 1153. Sep 20
46. A.J. Yellen-Shaw, E.J. Wherry, G.C. Dubois, and L.C. Eisenlohr Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein J. Immunol. 158 7 1 April, 1997 3227 3234
47. A.J. Yellen-Shaw, and L.C. Eisenlohr Regulation of class I-restricted epitope processing by local or distal flanking sequence J. Immunol. 158 4 15 February, 1997 1727 1733
48. L.L. An, and J.L. Whitton A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen J. Virol. 71 3 March, 1997 2292 2302
49. S.A. Thomson, M.A. Sherritt, J. Medveczky, S.L. Elliott, D.J. Moss, and G.J. Fernando Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination J. Immunol. 160 4 15 February, 1998 1717 1723
50. S.A. Thomson, S.L. Elliott, M.A. Sherritt, K.W. Sproat, B.E. Coupar, and A.A. Scalzo Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes J. Immunol. 157 2 15 July 1996 822 826